Treat to Target

POS0702 TREATMENT EFFICACY AND SAFETY OF ADALIMUMAB VERSUS TOCILIZUMAB COMBINED WITH METHOTREXATE AND GLUCOCORTICOIDS IN PATIENTS WITH ACTIVE AND SEVERE TAKAYASU ARTERITIS: A RANDOMIZED, OPEN-LABEL, HEAD-TO-HEAD STUDY
X. Kong, J. Wang, L. MA, H. Chen, Z. Ding, X. Jin, L. Jiang

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 636-637; DOI: 10.1136/annrheumdis-2023-eular.4610
POS0714 TREAT-TO-TARGET RECOMMENDATIONS IN GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA
C. Dejaco, A. Kerschbaumer, D. Aletaha, M. Bond, E. Hysa, D. Camellino, L. Ehlers, A. Abril, S. Appenzeller, M. C. Cid, B. Dasgupta, C. Duftner, P. Grayson, B. Hellmich, A. Hocevar, T. Kermani, E. Matteson, S. Mollan, L. Neill, C. Ponte, C. Salvarani, S. E. Sattui, W. A. Schmidt, P. Seo, J. Smolen, J. Thiel, C. Toro Gutiérrez, M. Whitlock, F. Buttgereit

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 643-644; DOI: 10.1136/annrheumdis-2023-eular.254
POS0748 TOWARD THE DEFINITION OF CUTOFF VALUES FOR DISEASE ACTIVITY STATES IN SYSTEMIC JADAS
A. I. Rebollo Giménez, Y. Vyzhga, L. Carlini, S. Rosina, E. Patrone, M. Katsikas, C. Saad-Magalhaes, D. El-Ghoneimy, Y. El Miedany, R. Khubchandani, P. Pal, G. Simonini, G. Filocamo, M. Gattinara, F. De Benedetti, D. Montin, A. Civino, M. O. Alsuweiti, V. Stanevicha, V. Chasnyk, E. Alexeeva, S. Al-Mayouf, S. Vilaiyuk, A. Ravelli

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 664-665; DOI: 10.1136/annrheumdis-2023-eular.1298
OP0112 EXPANSION OF ACTIVATED CD7+ CYTOTOXIC T CELLS AND NK CELLS IN SSC AND PREVENTION OF FIBROBLAST CONTRACTION THROUGH SELECTIVE IMMUNOTOXIN-MEDIATED DEPLETION OF THESE CELLS
T. I. Papadimitriou, P. Singh, A. Van Caam, M. Gorris, B. Walgreen, E. Vitters, M. Koenders, R. Smeets, M. Vonk, I. J. M. De Vries, P. Van der Kraan, M. Huijnen, H. Koenen, R. M. Thurlings

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 74-75; DOI: 10.1136/annrheumdis-2023-eular.768
POS1126 THERAPEUTIC RANGE OF HYDROXYCHLOROQUINE BLOOD LEVELS CAN REDUCE ODDS OF HIGH LUPUS DISEASE ACTIVITY
S. Garg, B. Chewning, S. Gomez, C. Bartels

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 890-891; DOI: 10.1136/annrheumdis-2023-eular.960
POS1201-HPR ADVANCED PRACTICE RHEUMATOLOGY NURSING FOR PATIENTS WITH GOUT TARGETS URATE, KNOWLEDGE, AND LIFESTYLE TO ENHANCE CHRONIC DISEASE OUTCOME
M. O’neill, D. Veale, E. Molloy, C. Orr, P. Minnock

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 933; DOI: 10.1136/annrheumdis-2023-eular.1537
POS1251 TREATMENT TAPERING IN SYSTEMIC SCLEROSIS: A 10-YEAR FOLLOW-UP STUDY
J. Ciaffi, S. Liem, N. Van Leeuwen, C. Allaart, T. Huizinga, J. De Vries-Bouwstra

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 966-967; DOI: 10.1136/annrheumdis-2023-eular.4139
POS0729 DIFFERENCES BETWEEN GLUCOCORTICOIDS, CONVENTIONAL DMARDS AND TOCILIZUMAB IN ACHIEVING DISEASE REMISSION AND IN PREVENTING THE PROGRESSION OF DAMAGE IN GIANT CELL ARTERITIS PATIENTS
F. Davanzo, L. Iorio, M. Codirenzi, R. Padoan, A. Doria

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 652-653; DOI: 10.1136/annrheumdis-2023-eular.5834
POS1152 ATTAINMENT OF EULAR/ERA-EDTA TREATMENT TARGETS IN THE FIRST YEAR IN LUPUS NEPHRITIS: A MULTICENTER OBSERVATIONAL STUDY
M. Pappa, M. Kosmetatou, A. Pieta, M. Nikoloudaki, E. Argyriou, C. Tsalapaki, A. Chalkia, T. Dimitroulas, M. Cheila, C. Papagoras, A. Goules, D. Petras, D. Vassilopoulos, K. A. Boki, P. Sfikakis, P. Voulgari, G. Bertsias, D. Boumpas, M. Tektonidou, A. Fanouriakis

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 907; DOI: 10.1136/annrheumdis-2023-eular.2599
POS1482 PREDICTORS AND CLINICAL SIGNIFICANCE OF LUPUS LOW DISEASE ACTIVITY STATE 12 MONTHS AFTER LUPUS NEPHRITIS
C. K. Cheung, S. C. W. Chan, C. S. Lau

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1097; DOI: 10.1136/annrheumdis-2023-eular.2905

Main menu

Treat to Target

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Treat to Target

Pages